SPONSOR
Ming-Yuan Chen
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Nasopharyngeal Carcinoma (NPC)Locally Advanced Head and Neck Squamous Cell CarcinomaNasopharyngeal Carcinoma
Ming-Yuan Chen is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Nasopharyngeal Carcinoma (NPC), Locally Advanced Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Carcinoma.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ming-Yuan Chen
How many clinical trials has Ming-Yuan Chen sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Ming-Yuan Chen, of which 3 are actively recruiting participants. These trials cover conditions including Nasopharyngeal Carcinoma (NPC), Locally Advanced Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ming-Yuan Chen research focus on?
Ming-Yuan Chen clinical trials span Nasopharyngeal Carcinoma (NPC), Locally Advanced Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Carcinoma. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ming-Yuan Chen clinical trial?
To participate in a Ming-Yuan Chen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ming-Yuan Chen trials with current recruitment status updated daily.
Clinical Trials by Ming-Yuan Chen
NCT07188584 Phase 3
Recruiting
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
Nasopharyngeal Carcinoma (NPC)
NCT07524452 Phase 3
Recruiting
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07328854 Phase 3
Recruiting
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology